Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 74, Issue 6, Pages 1233-1240
Publisher
BMJ
Online
2014-05-13
DOI
10.1136/annrheumdis-2013-205143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OP0147 Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial
- (2014) V. Rantalaiho et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
- (2013) Marije F. Bakker ANNALS OF INTERNAL MEDICINE
- Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias
- (2013) Lilian H D van Tuyl et al. ANNALS OF THE RHEUMATIC DISEASES
- A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
- (2013) Debby den Uyl et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria
- (2013) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Reporting of Noninferiority and Equivalence Randomized Trials
- (2013) Gilda Piaggio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis
- (2013) R Knevel et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
- (2012) Marloes Vermeer et al. ARTHRITIS RESEARCH & THERAPY
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Non-overlapping American College of Rheumatology response rates: A better way to report response in rheumatoid arthritis Clinical Trials
- (2010) Maarten Boers et al. ARTHRITIS AND RHEUMATISM
- Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
- (2010) Vappu Rantalaiho et al. ARTHRITIS RESEARCH & THERAPY
- Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
- (2009) RF van Vollenhoven et al. LANCET
- Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial
- (2008) L H D van Tuyl et al. ANNALS OF THE RHEUMATIC DISEASES
- Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis
- (2008) L. H. D. van Tuyl et al. RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started